I know virtually nothing about #PCD genes or their phenotypic features, but the gorgeous graphical abstract makes this paper understandable and relevant. Thank you Dr. Raidt et al. bit.ly/44AbHTY

Fountain of youth: #exercise, #diet (more veggies), GLP-1 drugs (for the #obese or those with #DM). The first 2 is for sure; I'm not so sure about the #GLP1 though.

Online today in ERJ ERS publications Proceedings of the 7th World Symposium on Pulmonary Hypertension An important landmark in Pulmonary hypertension clinical care and research Read all 16 articles open access at the ERJ ERS erj.ersjournals.com/cc/the-seventh…

Looks like the #Vancouver #OlympicGames was a real bargain. We should host another one in the near future

Well well, beta blockers may not be the panacea that some have made it out to be even among CVD population. Can we stop pursuing beta blockers for #COPD and use those resources for targets that may actually work?

Is it #genes or #environment? I wonder what their diets are like. I wonder about the quality of air they breathe. I suspect we are what we eat and breathe.

Devil is always in the details. Yes, hopeful but awaiting peer-review before rendering judgement.

NEJM/ERJ session please come

24 hour/d O2 is no better than 15 hr/d in terms of mortality in pts with hypoxemia and #COPD

Prof Humbert presents his exciting paper on sGC stimulator in #PAH, paper that is now online ⁦ERS publications⁩

Novel INHALED vasodilator

Tirzeparide for #OSA presentation by the incomparable ⁦Atul Malhotra, MD⁩

Marked improvement in #OSA with tirazeparide

DPP1 inhibitor for #bronchiectasis presented by Pro PJ McShane, the paper is now online ⁦ERS publications⁩

The BI 5mg and 2.5mg dose reduced exacerbations

Congratulations Marc

We believe that #Pulmonary #LongCovid (PLC) is related to small airway disease, characterised by inflammation. The key to the diagnosis is accurately measuring small airway dysfunction using physiologic and/or imaging tools. bit.ly/48WceB3